Comments to FDA: Gingivitis Extension Request Share page: Docket Number: 2005D-0240 CHPA and CTFA request a 60-day extension of the comment period on the Draft Guidance for Industry on Gingivitis: Development and Evaluation of Drugs for the Treatment and Prevention. Download Document Issues: OTC Medicines Related Posts Press Releases and Statements CHPA Response to Study Examining Prescription Acid Reflux Drugs Apr 25, 2024 Articles Polibrief: Consumer Data Privacy: State Efforts to Preserve Privacy Apr 16, 2024 Press Releases and Statements Self-Care Industry Representatives Participate in Capitol Hill Briefing Highlighting Legislative Priorities Apr 11, 2024